United States
Germany
Japan
United Kingdom
China
Recombinant Anti-CD28 (Clone 1C6)
| Applications | Bl, ELISA, FC |
| Reactivities | Dog |
Products
Anti-CD28 Reference Antibody (FR104)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-CD28 Reference Antibody (Theralizumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
Anti-CD28 Reference Antibody (lulizumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
Anti-CD28 [9.3], Mouse IgG2a, kappa
| Applications | Bl, ELISA, IF, IP |
| Reactivities | Human |
Anti-CD28 [9.3], Rabbit IgG, kappa
| Applications | Bl, ELISA, IF, IP |
| Reactivities | Human |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format for improved compatibility with existing reagents assays and techniques. |
Anti-CD28 antibody(DM63), Rabbit mAb
| Applications | ELISA, FC |
| Reactivities | Human |
Anti-CD28 antibody(DM64), Rabbit mAb
| Applications | ELISA, FC |
| Reactivities | Human |
Biotinylated Anti-CD28 antibody(DM64), Rabbit mAb
| Applications | ELISA, FC |
| Reactivities | Human |
Biotinylated Anti-CD28 antibody(DM63), Rabbit mAb
| Applications | ELISA, FC |
| Reactivities | Human |
Recombinant Anti-CD28 (Clone 15E8)
| Applications | ELISA, FC |
| Reactivities | Human |
Recombinant Anti-CD28 (Clone 15E8)
| Applications | ELISA, FC |
| Reactivities | Human |
